piperacillin has been researched along with Deafness, Transitory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| Bernstein, JM; Brummett, RE; Gorse, GJ; Levin, RD; Linzmayer, MI; Lorber, RR; Markowitz, N; Pegram, PS; Saravolatz, LD | 1 |
2 trial(s) available for piperacillin and Deafness, Transitory
| Article | Year |
|---|---|
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients.
Topics: Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Hearing Loss; Humans; Immune Tolerance; Infections; Middle Aged; Neoplasms; Netilmicin; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1986 |